Literature DB >> 21295720

The diagnostic assessment of canine lymphoma: implications for treatment.

Dorothee Bienzle1, William Vernau.   

Abstract

Lymphoma in dogs is a heterogeneous cancer with highly variable prognosis. Many types of canine lymphoma have similar counterparts in the World Health Organization classification of human lymphoid tumors. The most common variant of canine lymphoma is diffuse large B-cell lymphoma, which, if treated with multiagent chemotherapy, has a survival time of approximately 12 months. T-cell lymphomas are more heterogeneous and high- and low-grade variants are common, which necessitates classification beyond B- versus T-cell lineage.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2011        PMID： 21295720     DOI： 10.1016/j.cll.2010.10.001

Source DB:  PubMed          Journal:  Clin Lab Med        ISSN： 0272-2712            Impact factor:   1.935


  10 in total

1.  Development and characterization of 5 canine B-cell lymphoma cell lines.

Authors:  Allison L Zwingenberger; William Vernau; Changying Shi; Wensheng Yan; Xinbin Chen; Ira K Gordon; Michael S Kent
Journal:  Leuk Res       Date:  2011-12-01       Impact factor: 3.156

2.  Expression of blood hepatocyte-derived microRNA-122 in canine multicentric lymphoma with hepatic involvement.

Authors:  Eman S Ramadan; Adel Abdelbaset Kubesy; Taher Ahmed Baraka; Faisal Abdelsamad Torad; Shaymaa Ismaiel Salem; Noha Yousef Salem
Journal:  Vet Res Commun       Date:  2019-08-31       Impact factor: 2.459

3.  First pathological study of canine primary breast lymphoma and the description of its clinicopathological characteristics as an animal model for human primary breast lymphoma.

Authors:  Sanaz Rismanchi; Samad Muhammadnejad; Saeid Amanpour; Ahad Muhammadnejad
Journal:  Biomed Rep       Date:  2014-10-09

4.  Application of flow cytometry in diagnosing lymphomas in dogs and cats.

Authors:  Olga Aniołek; Zdzisław Gajewski; Sławomir Giziński
Journal:  Cent Eur J Immunol       Date:  2014-10-14       Impact factor: 2.085

5.  Optimisation and validation of a PCR for antigen receptor rearrangement (PARR) assay to detect clonality in canine lymphoid malignancies.

Authors:  Elspeth M Waugh; Alice Gallagher; Hayley Haining; Pamela E J Johnston; Francesco Marchesi; Ruth F Jarrett; Joanna S Morris
Journal:  Vet Immunol Immunopathol       Date:  2016-10-19       Impact factor: 2.046

6.  Composite lymphoma of concurrent T zone lymphoma and large cell B cell lymphoma in a dog.

Authors:  Arata Matsuyama; Dorothee Bienzle; Danielle Richardson; Nariman Deravi; Mei-Hua Hwang; Nikos Darzentas; Stefan M Keller
Journal:  BMC Vet Res       Date:  2019-11-16       Impact factor: 2.741

7.  Use of immune repertoire sequencing to resolve discordant microscopic and immunochemical findings in a case of T cell-rich large B cell lymphoma in a young dog.

Authors:  Gary Kwok Cheong Lee; Dorothee Bienzle; Stefan Matthias Keller; Mei-Hua Hwang; Nikos Darzentas; Haiyang Chang; Emily Rätsep; Rebecca Egan; Janet Beeler-Marfisi
Journal:  BMC Vet Res       Date:  2021-02-18       Impact factor: 2.741

8.  Evaluation of the Proliferative Activity of Diffuse Large B-Cell Lymphoma (DLBCL) in Dogs with Respect to Patient Eligibility for Anthracycline-Based Chemotherapy.

Authors:  Paweł Klimiuk; Wojciech Łopuszyński; Kamila Bulak; Adam Brzana
Journal:  Animals (Basel)       Date:  2021-04-20       Impact factor: 2.752

9.  Autologous peripheral blood hematopoietic cell transplantation in dogs with T-cell lymphoma.

Authors:  E E Warry; J L Willcox; S E Suter
Journal:  J Vet Intern Med       Date:  2014-01-27       Impact factor: 3.333

10.  The Comparative Diagnostic Features of Canine and Human Lymphoma.

Authors:  Davis M Seelig; Anne C Avery; E J Ehrhart; Michael A Linden
Journal:  Vet Sci       Date:  2016-06-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.